Related Experiment Videos

The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression

Heather E Cunliffe1, Markus Ringnér, Sven Bilke

  • 1Cancer Genetics Branch, National Human Genome Research Institute/NIH, 50 South Drive, Bethesda, MD 20892, USA.

Cancer Research
|November 13, 2003
PubMed

Insights

This study reveals how hormones and growth factors impact gene expression in breast cancer cells, uncovering links between cellular responses and patient tumor characteristics. Understanding these gene regulation patterns is key to breast cancer progression.

Area of Science:

  • Molecular biology
  • Genomics
  • Cancer research

Background:

  • Hormone and growth factor signaling are crucial in breast cancer development and progression.
  • The specific gene targets of signaling networks driving deregulated breast cancer growth remain largely unknown.

Purpose of the Study:

  • To investigate the dynamic transcriptional effects of various growth regulators on breast cancer cell lines.
  • To compare these gene regulation patterns with published tumor expression profiles.
  • To identify relationships between signaling pathways and clinical properties of breast tumors.

Main Methods:

  • Treatment of three breast cancer cell lines (MCF7, T-47D, MDA-MB-436) with nine different regulators of growth and differentiation.
  • Analysis of dynamic transcriptional effects and gene expression patterns.
  • Comparison of cell line data with published tumor expression profiles.
  • Gene ontology analysis to identify distinct biological responses.
  • Correlation analysis between drug-responsive genes and genes associated with estrogen receptor status and disease outcome.

Main Results:

  • Identified complex gene regulation patterns with unexpected overlaps between steroids and epidermal growth factor, and between fulvestrant and all-trans-retinoic acid.
  • Divided estrogen-responsive genes into two clusters, with only one linked to cell proliferation.
  • Highlighted functionally distinct biological responses to different mitogens using gene ontology.
  • Found significant correlations between drug-responsive gene clusters and genes predicting estrogen receptor status or patient outcomes.
  • Determined that most estrogen receptor status discriminators likely reflect intrinsic tumor differences rather than growth factor signaling.

Conclusions:

  • Diverse regulators of breast cancer growth have a significant impact on gene expression.
  • Cellular responses in culture correlate with key clinical properties of human breast tumors.
  • The study provides insights into the complex interplay of signaling networks in breast cancer progression and identifies potential therapeutic targets.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...